García-Sosa A. T.* "Benford's Law and Distributions for Better Drug Design",
Expert Opinion in Drug Discovery 2024, 19(2):131-137
[HTML],
[DOI],
[Free ePrint]
Isca V. M. S., ...
García-Sosa A. T.,
* Rijo P.* "Extraction optimization and reactivity of 7α-acetoxy-6β-hydroxyroyleanone and ability of its derivatives to modulate PKC isoforms",
Scientific Reports 2024, 16990
[HTML],
[DOI],
[PDF]
Ćurčić V. et al. "Quinoline-based Thiazolyl-Hydrazones Target Cancer Cells Through Autophagy Inhibition",
Archiv der Pharmazie 2024, 357:e2300426
[HTML],
[DOI],
[HTMLshare],
[PDF]
Araškov J. B.,
García-Sosa A. T.,
*, ... Filipović, N.* "Structural insights and photophysical properties of mononuclear and pentanuclear Zn(II) acetate complexes with pyridyl-based thiazolyl-hydrazones",
Polyhedron 2024, 262:117162
[HTML],
[DOI],
[Free ePrint till 26.09.2024]
Gastalho C. M., et al. "Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids against Cholinesterases: In Silico, In Vitro and In Vivo studies",
IJMS 2024, 25(20):11153.
[HTML],
[DOI],
[PDF]
De Rosa M. C.,* Purohit R.,*
García-Sosa A. T.* "Drug Repurposing: A Nexus of Innovation, Science, and Potential",
Scientific Reports 2023, 13:178
[HTML],
[DOI],
[PDF]
Peña-Guerrero J., Fernández-Rubio C.,
García-Sosa A. T., Nguewa P. "BRCT domains: Structure, functions, and implications in disease. New therapeutic targets for innovative drug discovery against infections",
Pharmaceuticals 2023, 15(7):1839
[HTML],
[DOI],
[PDF]
Hofmanova T., Marques C.,
García-Sosa A. T. ... Burke A. J. "
N-Substituted 3-Aminooxindoles and
N-Propargyl Derivatives: Potential Biological Activities against Alzheimer's Disease",
Results in Chemistry 2023, 6:101032
[HTML],
[DOI],
[PDF]
Yeh C. -Y. ...
García-Sosa A. T., Kollist H. "MPK12 in Stomatal CO
2 Signaling: Function Beyond its Kinase Activity",
New Phytologist 2023, 239(1):146-158
[HTML],
[DOI],
[PDF]
Isca V.M.S., Bangay G., Princiotto S., Saraíva L., Santos D.,
García-Sosa A.T., Rijo P. "Reactivity of 7α-acetoxy-6β-hydroxyroyleanone and ability of its derivatives to modulate PKC isoforms", 27 January
2023, preprint at Research Square
[HTML]
Koumpoura C. L., Nguyen M., Bijani C., Vendier L., Salina E. G., Buroni S., Degiacomi G., Cojean S., Loiseau P. M., Benoit-Vical F.,
García-Sosa A. T.*, Robert A.*, Baltas M.* "Design of Anti-infectious Agents from Lawsone in a Three-component Reaction with Aldehydes and Isocyanides",
ACS Omega 2022, 7:35635-35655
[HTML],
[DOI],
[PDF]
Hunt K. E.,
García-Sosa A. T., Shalima T., Maran U., Vilu R., Kanger T. "Synthesis of a human milk oligosaccharide 6'-galactosyllactose from
Candida antarctica lipase-B mediated deacetylation reaction products"
Organic & Biomolecular Chemistry 2022, 20:4724-4735
[HTML],
[DOI],
[PDF]
Busto N., Leitão-Castro J.,
García-Sosa A. T., Marques C. S., Freitas R., Burke A. J. "N-1,2,3-Triazole-Isatin Derivatives: Anti-proliferation effects and target identification in solid tumour cell lines"
RSC Medicinal Chemistry 2022, 13:970-977
[HTML],
[DOI],
[PDF]
Alov P. et al., "A comprehensive evaluation of Sdox, a promising H
2S-releasing doxorubicin for the treatment of chemoresistant tumors",
Frontiers in Pharmacology 2022, 13:831791
[HTML],
[DOI],
[PDF]
Peña-Guerrero J., Nguewa P.,*
García-Sosa A. T.* "Machine Learning, Artificial Intelligence, and Data Science Breaking into Drug Design and Neglected Diseases"
WIREs Computational Molecular Science 2021, 11(5):e1513
[HTML],
[DOI],
[PDF]
García-Sosa A. T.* "Androgen Receptor Binding Category Prediction with Deep Neural Networks and Structure-, Ligand-, and Statistically-Based Features"
Molecules 2021, 26:1285
[HTML],
[DOI],
[PDF]
Peña-Guerrero J., Fernández-Rubio C., Burguete-Mikeo A., El-Dirany R.,
García-Sosa A. T.*, Nguewa P.* "Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis"
International Journal of Molecular Sciences 2021, 22:10493
[DOI],
[PDF]
García-Sosa A. T.*, Maran, U.* "Combined Naïve Bayesian, Chemical Fingerprints, and Molecular Docking Classifiers to Model and Predict Androgen Receptor Binding Activity Data for Environmentally- and Health-Sensitive Substances"
International Journal of Molecular Sciences 2021, 22:6695
[DOI],
[PDF]
Estrada F. G. A., Miccoli S., Aniceto N.,*
García-Sosa A. T.*, Guedes R. C.* "Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma",
Molecules 2021, 26:5574
[HTML],
[DOI],
[PDF]
Dinic J., Efferth T.,
García-Sosa A. T. et al. "Repurposing Old Drugs to Fight Multidrug Resistant Cancers"
Drug Resistance Updates 2020, 52:100713
[HTML],
[DOI],
[PDF]
Mansouri K. et al. "CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity"
Environmental Health Perspectives 2020, 128(2):027002
[HTML],
[DOI],
[PDF]
Gütschow M. et al. "Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7"
Molecules 2020, 25(13):2968
[HTML],
[DOI],
[PDF]
Isca V. M. S., Sencanski M., Filipovic N., Santos D., Gasparovic A. C., Saraiva L., Afonso C., Rijo P.,*
García-Sosa A. T.* "Activity to Breast Cancer Cell Lines of Different Malignancy and Predicted Interaction with Protein Kinase C Isoforms of Royleanones"
International Journal of Molecular Sciences 2020, 20(10):3671
[HTML],
[DOI],
[PDF]
Vanden Eynde J. J., Mangoni A. A., Rautio J., Leprince J., Azuma Y.- T.,
García-Sosa A. T. et al. "Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6"
Molecules 2020, 25(1):119
[HTML],
[DOI],
[PDF]
García-Sosa A. T.* "Benford's Law in Medicinal Chemistry: Implications for Drug Design"
Future Medicinal Chemistry 2019, 11(17):2247-2253
[DOI],
[HTML],
[PDF],
[Data]
[Data and Code on GitHub]
Stevanovic S., Sencanski M., Danel M., Menendez C., Belguedj R., Bouraiou A., Nikolic K., Cojean S., Loiseau P. M., Glisic S., Baltas M.,
García-Sosa, A. T.* "Synthesis,
In Silico, and
In Vitro Evaluation of Antileishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged Against Antitargets"
Molecules 2019, 24(7):1282
[DOI],
[HTML],
[PDF]
Alcaro S., Bolognesi M. L.,
García-Sosa A. T., Rapposelli S. "Editorial: Multitarget Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation"
Frontiers in Chemistry 2019, 7:71
[HTML],
[DOI],
[PDF]
Vacas A., Fernandez-Rubio C., Algarabel M., Peña-Guerrero J., Larrea E., Formiga F. R.,
García-Sosa A. T., Nguewa P. A. "A Novel Serine/Threonine Protein Kinase, 'LmjF.22.0810' from
Leishmania major May Be Involved in the Resistance to Drugs Such as Paromomycin"
Biomolecules 2019, 9(11):723
[HTML],
[PDF]
Acurcio R. A., Leonardo-Sousa C.,
García-Sosa A. T., Florindo H. F., Guedes R. C. "Structural Insights and Binding Analysis for Determining the Molecular Bases for Programmed Cell Death Protein Ligand-1 Inhibition"
MedChemComm 2019, 10:1810-1818
[DOI],
[HTML],
[PDF]
Yosipof A., Guedes R. C.,
García-Sosa A. T.* "Data Mining and Machine Learning Models for Predicting Drug Likeness and their Disease or Organ Category"
Frontiers in Chemistry 2018, 6:162
[DOI],
[PDF]
Highlighted in the Specialty News
Technology Networks "Data Visualization in Biopharma: Leveraging AI, VR, and MR to Support Drug Discovery"
Borges A., Simões M., Todorovic T. R., Filipovic, N. R.,
García-Sosa A. T.* "Cobalt Complex with Thiazole Based Ligand as New
Pseudomonas aeruginosa Quorum Quencher, Biofilm Inhibitor, and Virulence Attenuator"
Molecules 2018, 23:1385
[DOI],
[HTML],
[PDF]
Roman B. I., Guedes R. C., Stevens C. V.,
García-Sosa A. T.* "Recovering Actives in Multiantitarget and Target Design of Analogs of the Myosin II Inhibitor Blebbistatin"
Frontiers in Chemistry 2018, 6:179
[DOI],
[PDF]
García-Sosa A. T.* "Designing Ligands for
Leishmania,
Plasmodium, and
Aspergillus N-Myristoyl Transferase with Specificity and Antitarget Safe Virtual Libraries"
Current Computer-Aided Drug Design 2018, 14(2):131-141
[DOI],
[PubMed]
Olsson M.,
García-Sosa A. T., Ryde U. "Binding Affinities of the Farnesoid X Receptor in the D3R Grand Challenge 2 Estimated by Free Energy Perturbation and Docking"
Journal of Computer-Aided Molecular Design 2018, 32(1):211-224
[DOI],
[HTML],
[PDF]
Piir G., Kahn I.,
García-Sosa A. T., Sild S., Ahte P., Maran U. "Best Practices for QSAR Model Reporting: Physical and Chemical Properties, Ecotoxicity, Environmental Fate, Human Health, and Toxicokinetics Endpoints"
Environmental Health Perspectives 2018, 126(12):126001
[DOI],
[PDF]
Ivanova L., Tammiku-Taul J.,
García-Sosa A. T., Sidorova Y., Saarma M., Karelson M. "Molecular Dynamics Simulations of the Interactions between Glial Cell Line Derived Neurotrophic Factor Family Receptor GFRalpha1 and Small Molecule Ligands"
ACS Omega 2018, 3(9):11407-11414
[DOI],
[PDF]
Elshaflu H.; Todorovic T.; Nikolic M.; Lolic A.; Visnjevac A.; Hagenow S.; Padrón J. M.;
García-Sosa A. T., Djordjevic I.; Grubisic S.; Stark H.; Filipovic N. "Selenazolyl Hydrazones as Novel Selective MAO Inhibitors with Antiproliferative and Antioxidant Activities: Experimental and In Silico Studies"
Frontiers in Chemistry 2018, 6:247
[DOI],
[PDF]
Viira B.,
García-Sosa A. T., Maran U. "Chemical Structure and Correlation Analysis of HIV 1 NNRT and NRT Inhibitors and Database Curated, Published Inhibition Constants with Chemical Structure in Diverse Datasets"
Journal of Molecular Graphics and Modelling 2017, 76:205-223
[DOI],
[PDF]
Glisic S., Sencanski M., Perovic V., Stevanovic S.,
García-Sosa A. T.* "Arginase Flavonoid Antileishmanial
In Silico Inhibitors Flagged Against Antitargets"
Molecules 2016, 21(5):589
[HTML],
[DOI],
[PDF]
Jakobson L., Vaahtera L., Tõldsepp K., Nuhkat M., Wang C., Wang Y.-S., Hõrak H., Valk E., Pechter P., Sindarovska Y., Tang J., Xiao C., Xu Y., Talas U. G.,
García-Sosa A. T., Kangasjärvi S., Maran U., Remm M., Roelfsema M. R. G., Hu H., Kangasjärvi J., Loog M., Schroeder J. I., Kollist H., Brosché M. "Natural Variation in
Arabidopsis Cvi-0 Accession Reveals an Important Role of MPK12 in Guard Cell CO
Signaling"
PLoS Biology 2016, 14(12):e2000322
[DOI],
[HTML],
[PDF]
F1000 Prime Recommended Article
Maurel C: F1000Prime Recommendation of [Jakobson L et al., PLoS Biol 2016 14(12):e2000322]. In F1000Prime, 10 Jan 2017; 10.3410/f.727080912.793526875
Viira B., Selyutina A.,
García-Sosa A. T., Karonen M., Sinkkonen J., Merits A., Maran U. "Design, Discovery, Modelling, Synthesis, and Biological Evaluation of Novel and Small, Low Toxicity s-Triazine Derivatives as HIV 1 Nonnucleoside Reverse Transcriptase Inhibitors"
Bioorganic & Medicinal Chemistry 2016, 24(11):2519-2529 B.V., A.S., and A.T.G.-S. contributed equally.
[HTML],
[DOI],
[PDF]
Freimann K., Arukuusk P., Kurrikoff K., Ferreira Vasconcelos L. D., Veiman K. -L., Uusna J., Margus H.,
García-Sosa A. T., Pooga M., Langel Ü. "Optimization of In Vivo DNA Delivery with NickFect Peptide Vectors"
Journal of Controlled Release 2016, 241:134-143
[HTML],
[DOI],
[PDF]
Selected for Cover Figure and Editorial Comment
By the Journal of Controlled Release
Takkis K.,
García-Sosa A. T., Sild S. "Virtual Screening for HIV Protease Inhibitors Using a Novel Database Filtering Procedure"
Molecular Informatics 2015, 34(6-7):485-492
[DOI],
[Abstract],
[PDF]
García-Sosa A. T.* "Role of Water Molecules and Hydration Properties in Modelling Ligand-Protein Interaction and Drug Design" Book Chapter, in "In Silico Drug Discovery and Design: Theory, Methods, Challenges and Applications" Cavasotto, C. (Ed.), CRC Press Ltd.
2015 393-410, ISBN 9781482217834, Taylor & Francis, Boca Raton
[HTML]
García-Sosa A.T.* and Maran U., "Improving the Use of Ranking in Virtual Screening against HIV 1 Integrase with Triangular Numbers and Including Ligand Profiling with Antitargets"
Journal of Chemical Information and Modeling 2014, 54(11):3172-3185
[DOI],
[Abstract] [PDF]
García-Sosa A. T.,* Tulp I., Langel K., Langel Ü. "Peptide Ligand Binding Modeling of siRNA with Cell Penetrating Peptides"
BioMed Research International 2014, 2014:257040
[DOI],
[PDF]
García-Sosa A. T.* "Hydration Properties of Ligands and Drugs in Protein Binding Sites: Tightly Bound, Bridging Water Molecules and their Effects and Consequences on Molecular Design Strategies"
Journal of Chemical Information and Modeling 2013, 53(6):1388-1405
[DOI],
[Abstract],
[PDF]
García-Sosa A. T.* and Maran U. "Drugs, Nondrugs, and Disease Category Specificity: Organ Effects by Ligand Pharmacology"
SAR and QSAR in Environmental Research 2013, 24(4):319-331
[DOI],
[HTML],
[PDF]
García-Sosa A. T.,* Oja M., Hetényi C., Maran U. "DrugLogit: Logistic Discrimination Between Drugs and Nondrugs Including Disease Specificity by Assigning Probabilities Based on Molecular Properties"
Journal of Chemical Information and Modeling 2012, 52(8):2165-2180
[DOI],
[Abstract],
[PDF]
García-Sosa A. T., Oja M., Hetényi C., Maran U. "Disease Specific Differentiation between Drugs and Nondrugs using Principal Component Analysis of their Molecular Descriptor Space"
Molecular Informatics 2012, 31:369-383
[DOI],
[HTML],
[PDF]
García-Sosa A. T., Maran U., Hetényi C. "Molecular Property Filters Describing Pharmacokinetics and Drug Binding"
Current Medicinal Chemistry 2012, 19:1646-1662
[PubMed 22376034],
[DOI],
[PDF]
García-Sosa A. T.,* Sild S., Takkis K., Maran U. "Combined Approach using Ligand Efficiency, Cross Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV 1 Reverse Transcriptase"
Journal of Chemical Information and Modeling 2011, 51(10):2595-2611
[DOI],
[HTML],
[PDF]
García-Sosa A. T.* and Mancera R. L. "Free Energy Calculations of Mutations Involving a Tightly Bound Water Molecule and Ligand Substitutions in a Ligand Protein Complex"
Molecular Informatics 2010, 29(8-9):589-600
[DOI],
[HTML],
[PDF]
'Hot Article in Biochemistry 2011'
Named by Wiley-VCH
García-Sosa A. T.,* Hetényi C., Maran U. "Drug Efficiency Indices for Improvement of Molecular Docking Scoring Functions"
Journal of Computational Chemistry 2010, 31(1):174-184
[DOI],
[HTML],
[PDF]
García-Sosa A. T.*, Sild S., Maran U. "Docking and Virtual Screening Using Distributed Grid Technology"
QSAR & Combinatorial Science 2009, 28(8):815-821
[DOI],
[PDF]
García-Sosa A. T.*, Sild S., Maran U. "Design of Multibinding Site Inhibitors, Ligand Efficiency, and Consensus Screening of Avian Influenza H5N1 Wild Type Neuraminidase and of the Oseltamivir Resistant H274Y Variant"
Journal of Chemical Information and Modeling 2008, 48:2074-2080
[DOI],
[HMTL],
[PubMed],
[PDF]
Hetényi C., Maran U.,
García-Sosa A. T., Karelson M. "Structure Based Calculation of Drug Efficiency Indices"
Bioinformatics 2007, 23(20):2678-2685
[HTML],
[PDF]
García-Sosa A. T.* and Mancera R. L. "The Effect of a Tightly Bound Water Molecule on Scaffold Diversity in the Computer Aided
De Novo Ligand Design of CDK2 Inhibitors"
Journal of Molecular Modeling 2006, 12(4):422-431
[DOI],
[PDF]
Park J. G., Sill P. C., Makiyi E. F.,
Garcia-Sosa A. T., Millard C. B., Schmidt J. J., Pang Y. P. "Serotype Selective, Small Molecule Inhibitors of the Zinc Endopeptidase of Botulinum Neurotoxin Serotype A"
Bioorganic & Medicinal Chemistry 2006, 14:395-408
[DOI],
[PDF]
García-Sosa A. T.*, Firth-Clark S., Mancera R. L. "Including Tightly Bound Water Molecules in De Novo Drug Design: Exemplification Through the In Silico Generation of Poly (ADP Ribose) Polymerase Ligands"
Journal of Chemical Information and Modeling 2005, 45:624-633
[DOI],
[HTML],
[PDF]
Lloyd D. G.,
García-Sosa A. T., Alberts I. L., Todorov N. P., Mancera R. L. "The Effect of Tightly Bound Water Molecules on the Structural Interpretation of Ligand Derived Pharmacophore Models"
Journal of Computer-Aided Molecular Design 2004, 18:89-100
[DOI],
[PDF]
García-Sosa A. T.*, Mancera R. L., Dean P. M. "WaterScore: A Novel Method for Distinguishing between Bound and Displaceable Water Molecules in the Crystal Structure of the Binding Site of Protein Ligand Complexes"
Journal of Molecular Modeling 2003, 9(3):172-182
[DOI],
[PDF]
García-Sosa A. T. and Castro M. "A Density Functional Study of FeO
2, FeO
2+, and FeO
2- "
International Journal of Quantum Chemistry 2000, 80(3):307-319
[DOI],
[PDF],
[TEX]
Ferri N. et al. "New Rac1 inhibitors as potential pharmacological agents for heart failure treatment" WO 2010119050
2010 [HTML],
[PDF]
Ferri N. et al. "Preparation of pyrimidinylamine as Rac1 inhibitors for the treatment of heart failure" EP 2241555
2010 [HTML],
[PDF]
~~~~~~
Please email me for a reprint of any of my papers, or click on the PDF links above
Reviewer for the peer-reviewed international journals:
ACS Medicinal Chemistry Letters, Advanced Theory and Simulations, Antiviral Research, BioFactors, Bioinformatics, Biomolecules, Chemical Science (RSC), ChemMedChem, Chemosphere, Combinatorial Chemistry and High-Throughput Screening, Computational Biology and Chemistry, Computer Methods and Programs in Biomedicine, Current Topics in Medicinal Chemistry, Drug Discovery Today, Frontiers in Chemistry: Theoretical and Computational Chemistry, Frontiers in Pharmacology: Experimental Pharmacology and Drug Discovery, Frontiers in Pharmacology: Medicinal and Pharmaceutical Chemistry, Future Medicinal Chemistry, International Journal of Antimicrobial Agents, International Journal of Molecular Sciences, Journal of Biomolecular Structure & Dynamics, Journal of Bionanotechnology, Journal of Chemical Information and Modeling, Journal of Computer-Aided Molecular Design, Journal of Computational Chemistry, Journal of the Mexican Chemical Society, Journal of Molecular Modeling, Journal of Molecular Structure, Medicinal Research Reviews, Molecular Informatics, Molecules, PLoS ONE, RSC Advances, and Scientific Reports (Nature Publishing Group)
ORCiD: 0000-0003-0542-4446,
ResearcherID,
Publons,
Google Scholar
2022 -> Core Group and Work Group Leader, EU COST Action CA2111 One Health drugs against parasitic vector borne diseases in Europe and beyond (OneHealthdrugs)
2019 -> 2023 Management Committee member, EU COST Action CA17104 New diagnostic and therapeutic tools against multidrug resistant tumors (Stratagem)
2019 -> 2023 Management Committee member, EU COST Action CA17129 Catalysing transcriptomics research in cardiovascular disease
2018 -> 2021 Scientific Communication Manager, EU CA COST Action CA15135
2017 -> 2022 Management Committee member, EU CA COST Action CA16225 Realising the therapeutic potential of novel cardioprotective therapies
2016 -> 2021 Management Committee member, EU CA COST Action CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig)
2013 -> 2018 Management Committee member, EU COST Action CM1307 Targeted chemotherapy towards diseases caused by endoparasites
Editorial Board Member of the WoS-indexed journals:
2018
-> Frontiers in Chemistry, Associate Editor, Issue
Muti-target directed ligands (MTDL) as challenging research tools in drug discovery: from design to pharmacological action
2016 -> Frontiers in Pharmacology, section Experimental Pharmacology and Drug Discovery
2015 -> Frontiers in Chemistry, section Medicinal and Pharmaceutical Chemistry
2014 -> Scientific Reports (Nature Publishing Group)
2013 -> Frontiers in Chemistry, section Theoretical and Computational Chemistry
2013 -> 2017 BioMed Research International
2011 -> 2019 Computational and Mathematical Methods in Medicine
Evaluator for the EU HaDEA Horizon research projects
Scientific Reviewer/Monitor for the EU EIC FET-Open PathFinder research projects
Evaluator for the EU Marie Curie Doctoral Networks (MSCA DN) proposals
EU COST Action External Evaluator
Expert Reviewer for the UK Research and Innovation (UKRI) research projects
Scientific Evaluator for the Italian Ministry of Education, University, and Research (MIUR)
Expert Reviewer for the Consejo Nacional de Ciencia y Tecnología of Mexico (CONACYT)
Scientific Reviewer for the National Science Centre of Poland (NCN)
Reviewer for the Hungarian Scientific Research Fund (OTKA)
Reviewer/Rapporteur for the Executive Agency for Higher Education, Research, Development, and Innovation Funding of Romania (UEFISCDI)
Evaluator for Research Projects, University of Parma, Italy
2021 -> National Researcher (abroad), Sistema Nacional de Investigadores, México
2016 Sentinel of Science award from Publons (Clarivate) for being in the top 10% of reviewers in the Biochemistry, Genetics, and Molecular Biology field
[HTML],
[PDF]
PhD University of Cambridge, UK
Overseas Research Scholarship Award by the Committee of Chancellors and Vice Chancellors of Universities in the UK
Post-doctoral Fellowship, Mayo Clinic, MN
------------------------~~oOo~~-----------------------